Gabelli Funds’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-110,900
| Closed | -$132K | – | 1317 |
|
|
2022
Q3 | $132K | Sell |
110,900
-2,000
| -2% | -$2.38K | ﹤0.01% | 1188 |
|
|
2022
Q2 | $203K | Sell |
112,900
-2,000
| -2% | -$3.6K | ﹤0.01% | 1188 |
|
|
2022
Q1 | $232K | Buy |
114,900
+5,000
| +5% | +$10.1K | ﹤0.01% | 1225 |
|
|
2021
Q4 | $298K | Hold |
109,900
| – | – | ﹤0.01% | 1183 |
|
|
2021
Q3 | $490K | Buy |
109,900
+5,000
| +5% | +$22.3K | ﹤0.01% | 1058 |
|
|
2021
Q2 | $608K | Buy |
104,900
+5,000
| +5% | +$29K | ﹤0.01% | 1003 |
|
|
2021
Q1 | $701K | Sell |
99,900
-55,200
| -36% | -$387K | ﹤0.01% | 974 |
|
|
2020
Q4 | $744K | Buy |
155,100
+3,200
| +2% | +$15.4K | 0.01% | 937 |
|
|
2020
Q3 | $886K | Buy |
151,900
+5,500
| +4% | +$32.1K | 0.01% | 845 |
|
|
2020
Q2 | $988K | Sell |
146,400
-3,000
| -2% | -$20.2K | 0.01% | 804 |
|
|
2020
Q1 | $950K | Buy |
149,400
+1,000
| +0.7% | +$6.36K | 0.01% | 790 |
|
|
2019
Q4 | $1.55M | Hold |
148,400
| – | – | 0.01% | 770 |
|
|
2019
Q3 | $583K | Buy |
148,400
+39,500
| +36% | +$155K | ﹤0.01% | 936 |
|
|
2019
Q2 | $1.62M | Buy |
108,900
+64,200
| +144% | +$954K | 0.01% | 806 |
|
|
2019
Q1 | $1.11M | Buy |
44,700
+29,800
| +200% | +$739K | 0.01% | 855 |
|
|
2018
Q4 | $268K | Buy |
14,900
+8,000
| +116% | +$144K | ﹤0.01% | 1048 |
|
|
2018
Q3 | $203K | Buy |
6,900
+1,500
| +28% | +$44.1K | ﹤0.01% | 1098 |
|
|
2018
Q2 | $246K | Sell |
5,400
-20,000
| -79% | -$911K | ﹤0.01% | 1074 |
|
|
2018
Q1 | $1.34M | Buy |
25,400
+6,900
| +37% | +$364K | 0.01% | 855 |
|
|
2017
Q4 | $1.26M | Buy |
18,500
+3,100
| +20% | +$211K | 0.01% | 867 |
|
|
2017
Q3 | $1.27M | Buy |
15,400
+6,600
| +75% | +$544K | 0.01% | 867 |
|
|
2017
Q2 | $824K | Buy |
+8,800
| New | +$824K | ﹤0.01% | 932 |
|